BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 31 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,965,372 | +15.9% | 4,003,000 | +17.6% | 0.00% | – |
| Q2 2023 | $3,421,070 | -61.8% | 3,403,000 | -60.4% | 0.00% | – |
| Q1 2023 | $8,962,585 | +43.1% | 8,593,000 | +47.4% | 0.00% | – |
| Q4 2022 | $6,262,536 | +20.6% | 5,828,000 | +11.5% | 0.00% | – |
| Q3 2022 | $5,192,000 | -22.1% | 5,228,000 | -22.0% | 0.00% | – |
| Q2 2022 | $6,661,000 | +36.4% | 6,703,000 | +37.4% | 0.00% | – |
| Q1 2022 | $4,884,000 | +34.6% | 4,878,000 | +40.3% | 0.00% | – |
| Q4 2021 | $3,628,000 | +4.2% | 3,478,000 | 0.0% | 0.00% | – |
| Q3 2021 | $3,481,000 | +16.7% | 3,478,000 | +16.8% | 0.00% | – |
| Q2 2021 | $2,984,000 | – | 2,978,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 52,002 | $52,121,000 | 3.69% |
| MACKAY SHIELDS LLC | 77,043,000 | $76,896,000 | 1.94% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,534,000 | $33,470,000 | 0.61% |
| LOOMIS SAYLES & CO L P | 2,190,467 | $185,686,000 | 0.38% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,139,000 | 0.09% |
| Jefferies Group LLC | 8,306,000 | $8,275,194 | 0.07% |
| THRIVENT FINANCIAL FOR LUTHERANS | 15,950,000 | $15,840,000 | 0.04% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13,700,000 | $13,605,000 | 0.03% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 14,000 | $14,000 | 0.02% |
| AVIVA PLC | 3,000,000 | $3,005,000 | 0.02% |